These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 25779383)
1. Immunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data. Vanobberghen FM; Kilama B; Wringe A; Ramadhani A; Zaba B; Mmbando D; Todd J Trop Med Int Health; 2015 Jul; 20(7):880-92. PubMed ID: 25779383 [TBL] [Abstract][Full Text] [Related]
2. CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone. Hoffmann CJ; Maritz J; van Zyl GU Trop Med Int Health; 2016 Feb; 21(2):219-23. PubMed ID: 26584666 [TBL] [Abstract][Full Text] [Related]
3. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings. Chang LW; Harris J; Humphreys E Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969 [TBL] [Abstract][Full Text] [Related]
4. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa. Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454 [TBL] [Abstract][Full Text] [Related]
5. Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort. Hawkins C; Hertzmark E; Spiegelman D; Muya A; Ulenga N; Kim S; Khudyakov P; Christian B; Sando D; Aris E; Fawzi W J Antimicrob Chemother; 2017 Jul; 72(7):2060-2068. PubMed ID: 28387836 [TBL] [Abstract][Full Text] [Related]
6. The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure. Davies MA; Boulle A; Technau K; Eley B; Moultrie H; Rabie H; Garone D; Giddy J; Wood R; Egger M; Keiser O; Trop Med Int Health; 2012 Nov; 17(11):1386-90. PubMed ID: 22974345 [TBL] [Abstract][Full Text] [Related]
7. High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania. Kroidl A; Burger T; Urio A; Mugeniwalwo R; Mgaya J; Mlagalila F; Hoelscher M; Däumer M; Salehe O; Sangare A; Lennemann T; Maganga L Trop Med Int Health; 2020 May; 25(5):579-589. PubMed ID: 31984634 [TBL] [Abstract][Full Text] [Related]
9. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M; Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252 [TBL] [Abstract][Full Text] [Related]
10. Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa. Schoffelen AF; Wensing AM; Tempelman HA; Geelen SP; Hoepelman AI; Barth RE PLoS One; 2013; 8(3):e58526. PubMed ID: 23505529 [TBL] [Abstract][Full Text] [Related]
11. Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania. Gunda DW; Kidenya BR; Mshana SE; Kilonzo SB; Mpondo BC BMC Res Notes; 2017 Jan; 10(1):45. PubMed ID: 28095920 [TBL] [Abstract][Full Text] [Related]
12. Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda. Ssempijja V; Nakigozi G; Chang L; Gray R; Wawer M; Ndyanabo A; Kasule J; Serwadda D; Castelnuovo B; Hoog AV; Reynolds SJ BMC Infect Dis; 2017 Aug; 17(1):582. PubMed ID: 28830382 [TBL] [Abstract][Full Text] [Related]
13. Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa. Rohr JK; Ive P; Horsburgh CR; Berhanu R; Shearer K; Maskew M; Long L; Sanne I; Bassett J; Ebrahim O; Fox MP PLoS One; 2016; 11(8):e0161469. PubMed ID: 27548695 [TBL] [Abstract][Full Text] [Related]
14. A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria. Gilks CF; Walker AS; Munderi P; Kityo C; Reid A; Katabira E; Goodall RL; Grosskurth H; Mugyenyi P; Hakim J; Gibb DM; PLoS One; 2013; 8(2):e57580. PubMed ID: 23437399 [TBL] [Abstract][Full Text] [Related]
15. Treatment Outcomes After Switching to Second-Line Anti-Retroviral Therapy: Results From the Thai National Treatment Program. Sudsila P; Teeraananchai S; Kiertiburanakul S; Lertpiriyasuwat C; Triamwichanon R; Gatechompol S; Putcharoen O; Chetchotisakd P; Avihingsanon A; Kerr SJ; Ruxrungtham K J Int Assoc Provid AIDS Care; 2023; 22():23259582231220513. PubMed ID: 38115729 [TBL] [Abstract][Full Text] [Related]
16. Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings. Kantor R; Diero L; Delong A; Kamle L; Muyonga S; Mambo F; Walumbe E; Emonyi W; Chan P; Carter EJ; Hogan J; Buziba N Clin Infect Dis; 2009 Aug; 49(3):454-62. PubMed ID: 19569972 [TBL] [Abstract][Full Text] [Related]
17. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. ; Keiser O; Tweya H; Boulle A; Braitstein P; Schecter M; Brinkhof MW; Dabis F; Tuboi S; Sprinz E; Pujades-Rodriguez M; Calmy A; Kumarasamy N; Nash D; Jahn A; MacPhail P; Lüthy R; Wood R; Egger M AIDS; 2009 Sep; 23(14):1867-74. PubMed ID: 19531928 [TBL] [Abstract][Full Text] [Related]
18. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy. Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463 [TBL] [Abstract][Full Text] [Related]
19. Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation. Desmonde S; Eboua FT; Malateste K; Dicko F; Ekouévi DK; Ngbeché S; Koueta F; Sy HS; Renner L; Koumakpai SA; Leroy V; AIDS; 2015 Jul; 29(12):1527-36. PubMed ID: 26244392 [TBL] [Abstract][Full Text] [Related]
20. Antiretroviral treatment failure predicts mortality in rural Tanzania. Pettersen PS; Brox IK; Naman E; Bruun JN; Dyrhol-Riise AM; Trøseid M; Johannessen A Int J STD AIDS; 2015 Aug; 26(9):633-9. PubMed ID: 25122578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]